DE602005016532D1 - Pharmazeutische zusammensetzung mit einem benzodiaeins - Google Patents
Pharmazeutische zusammensetzung mit einem benzodiaeinsInfo
- Publication number
- DE602005016532D1 DE602005016532D1 DE602005016532T DE602005016532T DE602005016532D1 DE 602005016532 D1 DE602005016532 D1 DE 602005016532D1 DE 602005016532 T DE602005016532 T DE 602005016532T DE 602005016532 T DE602005016532 T DE 602005016532T DE 602005016532 D1 DE602005016532 D1 DE 602005016532D1
- Authority
- DE
- Germany
- Prior art keywords
- pharmaceutical composition
- benzodia
- eins
- rsv
- diluent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0406279.0A GB0406279D0 (en) | 2004-03-19 | 2004-03-19 | Therapeutic compounds |
PCT/GB2005/001029 WO2005089771A1 (en) | 2004-03-19 | 2005-03-18 | Pharmaceutical composition comprising a benzodiazepine derivative and a inhibitor of the rsv fusion protein |
Publications (1)
Publication Number | Publication Date |
---|---|
DE602005016532D1 true DE602005016532D1 (de) | 2009-10-22 |
Family
ID=32118066
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE602005016532T Expired - Fee Related DE602005016532D1 (de) | 2004-03-19 | 2005-03-18 | Pharmazeutische zusammensetzung mit einem benzodiaeins |
Country Status (17)
Country | Link |
---|---|
US (1) | US20070185096A1 (de) |
EP (1) | EP1727551B1 (de) |
JP (1) | JP2007529491A (de) |
KR (1) | KR20070009630A (de) |
CN (1) | CN100496499C (de) |
AT (1) | ATE442145T1 (de) |
AU (1) | AU2005224159B2 (de) |
BR (1) | BRPI0507652A (de) |
CA (1) | CA2557931A1 (de) |
DE (1) | DE602005016532D1 (de) |
DK (1) | DK1727551T3 (de) |
ES (1) | ES2331479T3 (de) |
GB (1) | GB0406279D0 (de) |
PL (1) | PL1727551T3 (de) |
PT (1) | PT1727551E (de) |
RU (1) | RU2006136881A (de) |
WO (1) | WO2005089771A1 (de) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0406282D0 (en) * | 2004-03-19 | 2004-04-21 | Arrow Therapeutics Ltd | Therapeutic compounds |
JP2010501567A (ja) * | 2006-08-24 | 2010-01-21 | ノバルティス アクチエンゲゼルシャフト | 代謝系、心血管系および他の障害の処置のためのステアロイル−CoA不飽和化酵素(SCD)阻害剤としての2−(ピラジン−2−イル)−チアゾールおよび2−(1H−ピラゾール−3−イル)チアゾール誘導体ならびに関連化合物 |
BRPI0718509A2 (pt) | 2006-09-22 | 2015-09-29 | Novartis Ag | compostos orgânicos heterocíclicos |
JP2010513403A (ja) | 2006-12-20 | 2010-04-30 | ノバルティス アーゲー | Scd阻害剤としての2−置換5員ヘテロ環 |
AU2009244504A1 (en) * | 2008-05-05 | 2009-11-12 | Amgen Inc. | Urea compounds as gamma secretase modulators |
US9556236B1 (en) | 2012-11-29 | 2017-01-31 | University Of South Florida | Compositions and methods for treating respiratory syncytial virus infection |
LT3324977T (lt) | 2015-07-22 | 2022-10-25 | Enanta Pharmaceuticals, Inc. | Benzodiazepino dariniai kaip rsv inhibitoriai |
US20170226129A1 (en) | 2016-01-15 | 2017-08-10 | Enanta Pharmaceuticals, Inc. | Heterocyclic compounds as rsv inhibitors |
GB201613942D0 (en) * | 2016-08-15 | 2016-09-28 | Univ Of Durham The | An antimicrobial compound |
US10398706B2 (en) | 2017-01-06 | 2019-09-03 | Enanta Pharmaceuticals, Inc. | Heteroaryldiazepine derivatives as RSV inhibitors |
CA3065368A1 (en) * | 2017-02-16 | 2018-08-23 | Enanta Pharmaceuticals, Inc. | Processes for the preparation of benzodiazepine derivatives |
WO2018226801A1 (en) | 2017-06-07 | 2018-12-13 | Enanta Pharmaceuticals, Inc. | Aryldiazepine derivatives as rsv inhibitors |
US10851115B2 (en) | 2017-06-30 | 2020-12-01 | Enanta Pharmaceuticals, Inc. | Heterocyclic compounds as RSV inhibitors |
WO2019006295A1 (en) | 2017-06-30 | 2019-01-03 | Enanta Pharmaceuticals, Inc. | HETEROCYCLIC COMPOUNDS AS RSV INHIBITORS |
WO2019046364A1 (en) * | 2017-08-29 | 2019-03-07 | Emory University | INHIBITORS OF SYNCYTIAL RESPIRATORY VIRUS (RSV) REPLICATION AND USES THEREOF |
BR112020006334A2 (pt) | 2017-09-29 | 2020-09-24 | Enanta Pharmaceuticals, Inc. | combinação de agentes farmacêuticos como inibidores de rsv |
WO2019094920A1 (en) | 2017-11-13 | 2019-05-16 | Enanta Pharmaceuticals, Inc. | Azepin-2-one derivatives as rsv inhibitors |
CA3080138A1 (en) | 2017-11-13 | 2019-05-16 | Enanta Pharmaceuticals, Inc. | Processes for the resolution of benzodiazepin-2-one and benzoazepin-2-one derivatives |
WO2019199908A1 (en) | 2018-04-11 | 2019-10-17 | Enanta Pharmaceuticals, Inc. | Heterocyclic compounds as rsv inhibitors |
UY38614A (es) * | 2019-03-18 | 2020-10-30 | Enanta Pharm Inc | Derivados de benzodiazepinas como inhibidores del rsv |
US11179400B2 (en) | 2019-04-09 | 2021-11-23 | Enanta Pharmaceuticals, Inc. | Heterocyclic compounds as RSV inhibitors |
GB201911944D0 (en) * | 2019-08-20 | 2019-10-02 | Reviral Ltd | Pharmaceutical compounds |
CA3153297A1 (en) | 2019-10-04 | 2021-04-08 | Adam SZYMANIAK | Antiviral heterocyclic compounds |
US11505558B1 (en) | 2019-10-04 | 2022-11-22 | Enanta Pharmaceuticals, Inc. | Antiviral heterocyclic compounds |
GB201915273D0 (en) * | 2019-10-22 | 2019-12-04 | Reviral Ltd | Pharmaceutical compounds |
UY39032A (es) | 2020-01-24 | 2021-07-30 | Enanta Pharm Inc | Compuestos heterocíclicos como agentes antivirales |
WO2022010882A1 (en) | 2020-07-07 | 2022-01-13 | Enanta Pharmaceuticals, Inc, | Dihydroquinoxaline and dihydropyridopyrazine derivatives as rsv inhibitors |
US11945824B2 (en) | 2020-10-19 | 2024-04-02 | Enanta Pharmaceuticals, Inc. | Heterocyclic compounds as anti-viral agents |
MX2023009961A (es) | 2021-02-26 | 2023-09-05 | Enanta Pharm Inc | Compuestos heterociclicos antivirales. |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4324794A (en) * | 1980-08-26 | 1982-04-13 | Research Triangle Institute | Inhibition of respiratory syncytial virus-induced cell fusion by amidino compounds |
US4820834A (en) * | 1984-06-26 | 1989-04-11 | Merck & Co., Inc. | Benzodiazepine analogs |
EP0491218A1 (de) * | 1990-12-17 | 1992-06-24 | F. Hoffmann-La Roche Ag | Benzodiazepinone |
US6489338B2 (en) * | 2000-06-13 | 2002-12-03 | Bristol-Myers Squibb Company | Imidazopyridine and imidazopyrimidine antiviral agents |
US6919331B2 (en) * | 2001-12-10 | 2005-07-19 | Bristol-Myers Squibb Company | Substituted 2-methyl-benzimidazole respiratory syncytial virus antiviral agents |
PL369432A1 (en) * | 2001-12-10 | 2005-04-18 | Bristol-Myers Squibb Company | Bis hydrochloride monohydrate salt of rsv fusion inhibitor |
MXPA05002871A (es) * | 2002-09-20 | 2005-10-05 | Arrow Therapeutics Ltd | Derivados de benzodiazaepina y composiciones farmaceuticas que los contienen. |
GB0406282D0 (en) * | 2004-03-19 | 2004-04-21 | Arrow Therapeutics Ltd | Therapeutic compounds |
-
2004
- 2004-03-19 GB GBGB0406279.0A patent/GB0406279D0/en not_active Ceased
-
2005
- 2005-03-18 CA CA002557931A patent/CA2557931A1/en not_active Abandoned
- 2005-03-18 AU AU2005224159A patent/AU2005224159B2/en not_active Ceased
- 2005-03-18 DE DE602005016532T patent/DE602005016532D1/de not_active Expired - Fee Related
- 2005-03-18 RU RU2006136881/15A patent/RU2006136881A/ru not_active Application Discontinuation
- 2005-03-18 CN CNB2005800089207A patent/CN100496499C/zh not_active Expired - Fee Related
- 2005-03-18 ES ES05728747T patent/ES2331479T3/es active Active
- 2005-03-18 PL PL05728747T patent/PL1727551T3/pl unknown
- 2005-03-18 AT AT05728747T patent/ATE442145T1/de not_active IP Right Cessation
- 2005-03-18 US US10/593,382 patent/US20070185096A1/en not_active Abandoned
- 2005-03-18 WO PCT/GB2005/001029 patent/WO2005089771A1/en active Application Filing
- 2005-03-18 JP JP2007503412A patent/JP2007529491A/ja not_active Withdrawn
- 2005-03-18 KR KR1020067021651A patent/KR20070009630A/ko not_active Application Discontinuation
- 2005-03-18 PT PT05728747T patent/PT1727551E/pt unknown
- 2005-03-18 BR BRPI0507652-8A patent/BRPI0507652A/pt not_active IP Right Cessation
- 2005-03-18 EP EP05728747A patent/EP1727551B1/de not_active Not-in-force
- 2005-03-18 DK DK05728747T patent/DK1727551T3/da active
Also Published As
Publication number | Publication date |
---|---|
AU2005224159A1 (en) | 2005-09-29 |
US20070185096A1 (en) | 2007-08-09 |
ES2331479T3 (es) | 2010-01-05 |
AU2005224159B2 (en) | 2009-05-21 |
JP2007529491A (ja) | 2007-10-25 |
RU2006136881A (ru) | 2008-04-27 |
CN1933841A (zh) | 2007-03-21 |
GB0406279D0 (en) | 2004-04-21 |
ATE442145T1 (de) | 2009-09-15 |
KR20070009630A (ko) | 2007-01-18 |
EP1727551B1 (de) | 2009-09-09 |
EP1727551A1 (de) | 2006-12-06 |
CA2557931A1 (en) | 2005-09-29 |
PT1727551E (pt) | 2009-10-08 |
WO2005089771A1 (en) | 2005-09-29 |
CN100496499C (zh) | 2009-06-10 |
PL1727551T3 (pl) | 2010-02-26 |
DK1727551T3 (da) | 2009-12-14 |
BRPI0507652A (pt) | 2007-07-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE602005016532D1 (de) | Pharmazeutische zusammensetzung mit einem benzodiaeins | |
DE602005015686D1 (de) | Pharmazeutische zusammensetzung mit einem benzodiaeins | |
ES2525410T3 (es) | Composiciones y métodos para el tratamiento de enfermedades hiperproliferativas dérmicas | |
AU2003264038A1 (en) | Combination pharmaceutical agents as inhibitors of hcv replication | |
WO2006128184A3 (en) | Pyrimidine or triazine fused bicyclic metalloprotease inhibitors | |
HN2003000054A (es) | Formas de dosificacion farmaceutica de liberacion controlada de un inhibidor de la proteina de transferencia de ester de colesterilo (cetpi), a procedimientos de uso y a procedimientos de preparacion de las mismas. | |
EA200401019A1 (ru) | Дозированная лекарственная форма для перорального применения, содержащая ингибитор pde 4 в качестве действующего вещества и поливинилпирролидон в качестве вспомогательного вещества | |
WO2001076574A3 (en) | Novel medical use of aldosterone synthase inhibitors alone or in combination with at1-receptor antagonists | |
AU2003223352A1 (en) | Transparent consistent active replication of multithreaded application programs | |
MX2009004203A (es) | Combinaciones de paracetamol/ibuprofeno y metodo para su uso. | |
DE60316552D1 (de) | Tablette mit hohem wirkstoffgehalt | |
ECSP056194A (es) | Derivados de pirazolo-quinazolina, procedimiento para su preparacion y su uso como inhibidores de quinasa | |
EA200400991A1 (ru) | Фармацевтические композиции, содержащие ингибиторы протеазы вируса гепатита c | |
GEP20074047B (en) | Pramipexole once-daily dosage form | |
NO20051654L (no) | Forlenget frigjoring av farmasoytisk preparat | |
UY28897A1 (es) | Ácido 2-((2-(2-metilaminopirimidin-4-il)-1h-indol-5-carbonil)amino)-3-(fenilpiridin-2-ilamino)propiónico sustancialmente puro como inhibidor de la cinasa ikb | |
EA200401227A1 (ru) | Система доставки лекарства с контролируемым высвобождением, включающая правастатин | |
IL179206A0 (en) | Pyrrolylpyrimidine derivatives and pharmaceutical compositions containing the same | |
DE602005021475D1 (de) | Magenresistente pharmazeutische dosierform mit n-(2-(2-phthalimidoethoxy)-acetyl)-l-alanyl-d-glutaminsäure (lk-423) | |
AR056517A1 (es) | Composiciones y metodos farmaceuticos utilizando temozolomida y un inhibidor de la proteina quinasa | |
WO2004016741A3 (en) | Prenylation inhibitors containing dimethyl-cyclobutane and methods of their synthesis and use | |
WO2003068157A3 (en) | Kinase inhibitors and methods of use thereof | |
EA200401137A1 (ru) | Фармацевтическая композиция, содержащая ингибитор pde4 или pde3/4 и антагонист гистаминового рецептора | |
ATE479428T1 (de) | Olanzapin enthaltende pharmazeutische zusammensetzung | |
PA8519501A1 (es) | Farnesil transferasa inhibidora del enantiomero de quinolina 1,2-anillado |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |